Xing Liu

Title: Xing Liu and Inflammation-Inhibiting Compounds.

Introduction

Xing Liu is an inventor based in Boston, Massachusetts. His work includes a patent application describing compounds designed to inhibit inflammation-related cellular processes.

Latest Patents

Liu is associated with 1 patent, titled “Compounds for Inhibition of Inflammation.” The application describes chemical compounds that may inhibit gasdermin pore formation, inflammasome-mediated cell death (pyroptosis), cytokine secretion, and inflammatory caspase activity. It also describes compounds that can react covalently with a cysteine in a gasdermin protein. The proposed compounds may have applications in treating or preventing conditions linked to inflammasome activation, including sepsis.

Career Highlights

Liu is associated with Children’s Medical Center Corporation. The patent application reflects research into potential approaches for addressing inflammation and diseases involving inflammasome activation.

Collaborations

Hao Wu and Judy Lieberman are identified as Liu’s coworkers, reflecting a research environment connected to his work on inflammation-related compounds.

Conclusion

Xing Liu’s patent work focuses on compounds that may affect gasdermin activity, pyroptosis, and other inflammation-related processes, with potential relevance to conditions such as sepsis.